Belmora Flanax Tablet
Product Images NDC 27854-555

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Belmora Flanax (NDC 27854-555). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Belmora Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Belmora (Belmora Flanax Marksans Label 7 9 20)

This is a description of a pain reliever and fever reducer product that provides longer-lasting pain relief. There are warnings and information about allergy alert, stomach bleeding risk, heart attack & stroke risk, pregnant or breast-feeding, and directions to use. The product contains Naproxen Sodium and has 20 dual packets of 220mg tablets, with 1 tablet per packet. The product is manufactured in India and distributed by Belmora LLC, located in Arlington, VA.*

FDA Label Image

Drug Facts

FDA Label Image

Flanax 24ct Carton Marksans Proof Final

FDA Label Image

Af5e42f7 D165 0af1 E053 2995a90ac09b

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.